ImageneBio (IMA) Cash from Operations (2020 - 2024)
Historic Cash from Operations for ImageneBio (IMA) over the last 5 years, with Q4 2024 value amounting to -$28.2 million.
- ImageneBio's Cash from Operations fell 2906.18% to -$28.2 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$46.0 million, marking a year-over-year increase of 4230.97%. This contributed to the annual value of -$46.0 million for FY2024, which is 4230.97% up from last year.
- As of Q4 2024, ImageneBio's Cash from Operations stood at -$28.2 million, which was down 2906.18% from $13.0 million recorded in Q3 2024.
- ImageneBio's Cash from Operations' 5-year high stood at $13.0 million during Q3 2024, with a 5-year trough of -$28.2 million in Q4 2024.
- Over the past 5 years, ImageneBio's median Cash from Operations value was -$17.4 million (recorded in 2022), while the average stood at -$14.9 million.
- In the last 5 years, ImageneBio's Cash from Operations crashed by 13455.02% in 2021 and then surged by 16481.97% in 2024.
- Quarter analysis of 5 years shows ImageneBio's Cash from Operations stood at -$12.6 million in 2020, then dropped by 6.35% to -$13.4 million in 2021, then tumbled by 32.07% to -$17.7 million in 2022, then decreased by 23.59% to -$21.8 million in 2023, then dropped by 29.06% to -$28.2 million in 2024.
- Its Cash from Operations was -$28.2 million in Q4 2024, compared to $13.0 million in Q3 2024 and -$12.5 million in Q2 2024.